Corneal Confocal Microscopy: a Surrogate Endpoint for Neurodegeneration in Clinical Trials


POSTPONED TO A LATER DATE TO BE ANNOUNCED

Roy Freeman, MBChB

Roy Freeman
Professor of Neurology, Harvard Medical School
Director, Center for Autonomic and Peripheral Nerve Disorders
Harvard Medical School
Boston, MA, USA

Roy Freeman is Professor of Neurology at the Harvard Medical School and director of the Center for Autonomic and Peripheral Nerve Disorders in the Department of Neurology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr. Freeman is past President of the American Autonomic Society, past chairman of the World Federation of Neurology research group on the autonomic nervous system, and past chairman of the Autonomic Section of the American Academy of Neurology. He is currently Chairman of Consortium on Clinical Endpoints and Procedures for Peripheral Neuropathy Trials, subgroup of Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION), a public-private partnership with the United States FDA. Dr. Freeman is Editor of Autonomic Neuroscience – Basic and Clinical and on the editorial board of the Clinical Autonomic Research, Clinical Journal of Pain and Pain Reports. His research and clinical interests are the physiology and pathophysiology of the small nerve fibers and the autonomic nervous system. He his research encompasses the neurological complications of diabetes; neuropathic pain; the autonomic complications of neurodegenerative disease such as Parkinson’s disease and multiple system atrophy; and the diagnosis and treatment of autonomic and peripheral nervous system disorders. He has been principal investigator on many neuropathic pain clinical trials. He is the principal investigator on National Institutes of Health-funded studies on the neurological complications of diabetes, on cutaneous biomarkers in neurodegenerative disease and the neurobiology of stress.